Antibacterial therapy: use of ofloxacin
Systemic therapy forms the basis of conservative treatment for urogenital infections—which include prostatitis, as well as gonorrhea, pyelonephritis, cystitis, and urethritis. One of the key drugs in clinical practice is ofloxacin.
Beyond urology, the systemic use of this antibiotic covers a wide range of conditions:
- Respiratory tract and ENT organs: acute exacerbations of bronchitis, various pneumonias, sinusitis, otitis media, pharyngitis, and tracheitis.
- Other localizations: infectious lesions of the skin, soft tissues, abdominal cavity, pelvic organs, and osteoarticular system.
- Specific therapy: the drug is included in combination treatment regimens for drug-resistant forms of tuberculosis.
In surgery, ofloxacin is also used for prophylaxis to prevent bacterial complications directly in the postoperative period. In ophthalmological practice, it is used exclusively topically (as ointments or drops) for bacterial keratitis, conjunctivitis, and blepharitis.
Hemostatic therapy: indications in prostatitis and surgical pathology
In clinical practice, prostatitis is included in the list of strict indications for the use of antifibrinolytic hemostatic agents. This group of drugs is also vital for trauma, major surgical interventions, childbirth, and menorrhagia.
Antifibrinolytics are used for a wide range of hemostatic disorders:
- Liver diseases accompanied by impaired synthesis of inhibitors and clotting factors.
- Overdose of fibrinolytic drugs.
- Pathological primary activation of fibrinolysis, including disseminated intravascular coagulation (DIC).
- Hemorrhagic syndrome in thrombocytopenia and inherited thrombocytopathies (glycoprotein IIb/IIIa deficiency) — in this case, a combination of tranexamic acid, etamsylate, and vitamins C and P is used.
- Mild bleeding and minor surgical interventions in rare inherited coagulopathies (factor II, VII, X deficiency), where tranexamic acid monotherapy also enables the prevention of postoperative hemorrhagic syndrome.
- Hemorrhagic syndrome associated with acute hepatitis A. In this case, a 5% aminocaproic acid solution (200 ml IV drip twice daily) is used in strict combination with fresh frozen plasma (300–400 ml). This regimen has a level of evidence UUR C (LED 5).
Tranexamic acid is also the first-line drug in non-hormonal hemostatic therapy for abnormal uterine bleeding, reducing blood loss by 40–60% (level of recommendation A, LED 2). In hemophilia, antifibrinolytics (ATC group B02A) are prescribed as adjunctive therapy to stop bleeding.
Emergency management of bleeding
Pending coagulation profile results, the patient must receive general emergency hemostatic therapy. The standard intravenous regimen includes the administration of 10 ml of a 10% calcium chloride solution (alternative: 10 ml of a 10% calcium gluconate solution) or 10 ml of a 1% aminomethylbenzoic acid solution ("Amben"). These drugs must be administered simultaneously with 2–4 ml of a 5% ascorbic acid solution.
To stop capillary and parenchymal bleeding (e.g., in massive liver trauma), topical agents such as hemostatic sponges and thrombin are actively used.
Differentiated therapy based on the etiology of bleeding
Once the exact cause of bleeding is identified, treatment tactics are adjusted according to the etiological factor:
| Cause | Drug and administration regimen |
|---|---|
| Decreased prothrombin (cirrhosis, hepatitis) | Menadione sodium bisulfite (Vikasol): IM 1 ml of a 1% solution 1–2 times/day; orally 0.015 g 2 times/day. |
| Increased fibrinolysis | Epsilon-aminocaproic acid: orally 2–3 g 3–5 times/day; IV drip 100 ml of a 5% solution. |
| Vascular permeability / anticoagulant overdose | Rutoside (Rutin): orally 0.02–0.05 g 2–3 times a day. |
| Need for a rapid effect | Etamsylate (Dicynone): IV 2 ml of a 12.5% solution, then IM 2 ml or orally 0.5 g every 4–6 hours. |
If bleeding is accompanied by concomitant hypertension, the combination of local bleeding control and adequate antihypertensive therapy is of paramount importance, as blood loss ceases rapidly only after arterial blood pressure is lowered.
Class and exam questions
Why is ofloxacin prescribed in a surgical hospital?
The drug is used for systemic therapy of various infections, as well as for the strict prevention of bacterial complications in the postoperative period.
By what percentage does tranexamic acid reduce blood loss in abnormal uterine bleeding?
As a first-line non-hormonal hemostatic therapy, it reliably reduces blood loss by 40–60%.
Which drugs are administered emergently before obtaining a coagulation profile?
Administer 10% calcium chloride or calcium gluconate solution, or 1% aminomethylbenzoic acid solution intravenously, together with 5% ascorbic acid solution.
What is the treatment regimen for hemorrhagic syndrome in acute hepatitis A?
A 5% aminocaproic acid solution (200 ml IV drip twice daily) is used in mandatory combination with 300–400 ml of fresh frozen plasma.
What else to study on this topic
- Mechanism of action of antifibrinolytic agents
- Principles of therapy for rare coagulopathies (factor II, VII, X deficiency)
- Use of hemostatic sponges and thrombin
- Ofloxacin in the treatment of drug-resistant forms of tuberculosis
- Correction of hemostasis in thrombocytopenia and thrombocytopathies
Master the entire topic in the "General Surgery" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Prostatitis" and 3,335 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 70 video lessons on the subject
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.